<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl10364</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-10364</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая эндокринология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical endocrinology</subject></subj-group></article-categories><title-group><article-title>Эндоморфины: структура, локализация, иммунорегуляторная активность</article-title><trans-title-group xml:lang="en"><trans-title>Endomorphins: structure, localization, immunoregulatory activity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0799-3397</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гейн</surname><given-names>Сергей Владимирович</given-names></name><name name-style="western" xml:lang="en"><surname>Gein</surname><given-names>Sergey V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><email xlink:type="simple">gein@iegm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3827-7876</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баева</surname><given-names>Татьяна Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Baeva</surname><given-names>Tatyana A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н.</p></bio><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">simonjkaperm80@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт экологии и генетики микроорганизмов – филиал ФГБУН Пермский федеральный исследовательский центр Уральского отделения Российской академии наук; Пермский государственный национальный исследовательский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of ecology and genetics of microorganisms - branch of the Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences; Perm State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт экологии и генетики микроорганизмов – филиал ФГБУН Пермский федеральный исследовательский центр Уральского отделения Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of ecology and genetics of microorganisms - branch of the Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>04</day><month>08</month><year>2020</year></pub-date><volume>66</volume><issue>1</issue><fpage>78</fpage><lpage>86</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гейн С.В., Баева Т.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Гейн С.В., Баева Т.А.</copyright-holder><copyright-holder xml:lang="en">Gein S.V., Baeva T.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/10364">https://www.probl-endojournals.ru/jour/article/view/10364</self-uri><abstract><p>Эндоморфины – эндогенные тетрапептиды, обладающие высокой аффинностью к μ-опиатным рецепторам. Выделено и охарактеризовано два тетрапептида, различающихся по одному аминокислотному остатку. Структура эндоморфинов отличается от структуры представителей трех основных семейств опиоидных пептидов: эндорфинов, энкефалинов и динорфинов, которые содержат одинаковую N-концевую последовательность. В центральной нервной системе эндоморфины распределены повсеместно, где они в первую очередь ответственны за антиноцицепцию. Локализация эндоморфинов в иммунной системе схожа с таковой у других опиоидных пептидов, что позволило предположить их активное участие в процессах иммунорегуляции. В настоящем обзоре суммированы современные представления о структуре эндоморфинов, их локализации, возможных внутриклеточных механизмах передачи сигнала, а также влиянии на процессы активации, пролиферации и дифференцировки клеток врожденного и адаптивного иммунитета. Эндоморфины активно модулируют функции клеток иммунной системы, при этом если реакции адаптивного иммунитета пептиды преимущественно подавляют, то оказываемые ими эффекты на функции клеток врожденного иммунитета (гранулоциты, моноциты-макрофаги, дендритные клетки) в зависимости от условий могут иметь как угнетающую, так и стимулирующую направленность. Таким образом, эндоморфины могут являться перспективными соединениями, способными эффективно регулировать как ноцицептивные сигналы, так и процессы, протекающие в иммунной системе.</p></abstract><trans-abstract xml:lang="en"><p>Endomorphins – endogenous tetrapeptides with the highest affinity for the µ-opioid receptor. Currently, two tetrapeptides that differ in one amino acid residue have been isolated and characterized. The structure of endomorphins differs from the structure of members of three main families of opioid peptides: endorphins, enkephalins, and dynorphins, which contain the same N-terminal sequence. In the central nervous system, endomorphins are distributed everywhere, where they are primarily responsible for antinociception. Distribution of endomorphins in the immune system, similar to that of other opioid peptides, has allowed to suggest their active participation in the processes of immune regulation. This review summarizes modern views on the structure of endomorphins, their localization, possible intracellular mechanisms of signal transmission and their effects on the processes of activation, proliferation and differentiation of cells of innate and adaptive immunity. Endomorphins actively modulate the functions of the cells of the immune system. Peptides predominantly suppress adaptive immunity reactions. There effects on the functions of innate immunity cells (granulocytes, macrophages, monocytes, dendritic cells) depending on the conditions and can have either an inhibitory or stimulating orientation. Thus, endomorphins can be promising compounds that can effectively regulate both nociceptive signals and processes in the immune system.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эндоморфины</kwd><kwd>опиоидные рецепторы</kwd><kwd>иммунорегуляция</kwd><kwd>цитокины</kwd><kwd>макрофаг</kwd><kwd>гранулоцит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>endomorphins</kwd><kwd>opioid receptors</kwd><kwd>immunoregulation</kwd><kwd>cytokines</kwd><kwd>macrophage</kwd><kwd>granulocyte</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci U S A. 1993;90(12):5391−5393. doi: https://doi.org/10.1073/pnas.90.12.5391</mixed-citation><mixed-citation xml:lang="en">Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci U S A. 1993;90(12):5391−5393. doi: https://doi.org/10.1073/pnas.90.12.5391</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zadina JE, Hackler L, Ge LJ, Kastin AJ. A potent and selective endogenous agonist for the mu-opiate receptor. Nature (Lond). 1997;386:499–502. doi: https://doi.org/10.1038/386499a0</mixed-citation><mixed-citation xml:lang="en">Zadina JE, Hackler L, Ge LJ, Kastin AJ. A potent and selective endogenous agonist for the mu-opiate receptor. Nature (Lond). 1997;386:499–502. doi: https://doi.org/10.1038/386499a0</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Smith EM. Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis. Brain Behav Immun. 2008;22(1):3−14. doi: https://doi.org/10.1016/j.bbi.2007.08.005</mixed-citation><mixed-citation xml:lang="en">Smith EM. Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis. Brain Behav Immun. 2008;22(1):3−14. doi: https://doi.org/10.1016/j.bbi.2007.08.005</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hackler L, Zadina JE, Ge LJ, Kastin AJ. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides. 1997;18(10):1635−1639. doi: https://doi.org/10.1016/s0196-9781(97)00259-3</mixed-citation><mixed-citation xml:lang="en">Hackler L, Zadina JE, Ge LJ, Kastin AJ. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides. 1997;18(10):1635−1639. doi: https://doi.org/10.1016/s0196-9781(97)00259-3</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mizusawa K. Endomorphin. In: Takei Y, Ando H, Tsutsui K, ed. Handbook of hormones: comparative endocrinology for basic and clinical research. Oxford: Academic Press; 2016. Рp. 62−63</mixed-citation><mixed-citation xml:lang="en">Mizusawa K. Endomorphin. In: Takei Y, Ando H, Tsutsui K, ed. Handbook of hormones: comparative endocrinology for basic and clinical research. Oxford: Academic Press; 2016. Рp. 62−63</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fichna J, Janecka A, Costentin J, Do Rego JC. The endomorphin system and its evolving neurophysiological role. Pharmacol Rev. 2007;59(1):88−123. doi: https://doi.org/10.1124/pr.59.1.3</mixed-citation><mixed-citation xml:lang="en">Fichna J, Janecka A, Costentin J, Do Rego JC. The endomorphin system and its evolving neurophysiological role. Pharmacol Rev. 2007;59(1):88−123. doi: https://doi.org/10.1124/pr.59.1.3</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mizoguchi H, Sakurada T, Sakurada S. Endomorphins. In: Kastin A, ed. Handbook of biologically active peptides Oxford: Academic Press; 2013. Рp. 1556−1561.</mixed-citation><mixed-citation xml:lang="en">Mizoguchi H, Sakurada T, Sakurada S. Endomorphins. In: Kastin A, ed. Handbook of biologically active peptides Oxford: Academic Press; 2013. Рp. 1556−1561.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Finley JC, Lindstrom P, Petrusz P. Immunocytochemical localization of β-endorphin-containing neurons in the rat brain. Neuroendocrinology. 1981;33(1):28−42. doi: https://doi.org/10.1159/000123197</mixed-citation><mixed-citation xml:lang="en">Finley JC, Lindstrom P, Petrusz P. Immunocytochemical localization of β-endorphin-containing neurons in the rat brain. Neuroendocrinology. 1981;33(1):28−42. doi: https://doi.org/10.1159/000123197</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jessop DS, Major GN, Coventry TL, et al. Novel opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian immune tissues. J Neuroimmunol. 2000;106(1−2):53−59. doi: https://doi.org/10.1016/s0165-5728(99)00216-7</mixed-citation><mixed-citation xml:lang="en">Jessop DS, Major GN, Coventry TL, et al. Novel opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian immune tissues. J Neuroimmunol. 2000;106(1−2):53−59. doi: https://doi.org/10.1016/s0165-5728(99)00216-7</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mousa SA, Machelska H, Schafer M, Stein C. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol. 2002;126(1−2):5−15. doi: https://doi.org/10.1016/s0165-5728(02)00049-8</mixed-citation><mixed-citation xml:lang="en">Mousa SA, Machelska H, Schafer M, Stein C. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol. 2002;126(1−2):5−15. doi: https://doi.org/10.1016/s0165-5728(02)00049-8</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Seale JV, Jessop DS, Harbuz MS. Immunohistochemical staining of endomorphin 1 and 2 in the immune cells of the spleen. Peptides. 2004;25(1):91−94. doi: https://doi.org/10.1016/j.peptides.2003.11.016</mixed-citation><mixed-citation xml:lang="en">Seale JV, Jessop DS, Harbuz MS. Immunohistochemical staining of endomorphin 1 and 2 in the immune cells of the spleen. Peptides. 2004;25(1):91−94. doi: https://doi.org/10.1016/j.peptides.2003.11.016</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Jessop DS, Richards LJ, Harbuz MS. Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation. Ann N Y Acad Sci. 2002;966:456−463. doi: https://doi.org/10.1111/j.1749-6632.2002.tb04247.x</mixed-citation><mixed-citation xml:lang="en">Jessop DS, Richards LJ, Harbuz MS. Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation. Ann N Y Acad Sci. 2002;966:456−463. doi: https://doi.org/10.1111/j.1749-6632.2002.tb04247.x</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Van Dorpe S, Adriaens A, Polis I, et al. Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides. Peptides. 2010;31(7):1390−1399. doi: https://doi.org/10.1016/j.peptides.2010.03.029</mixed-citation><mixed-citation xml:lang="en">Van Dorpe S, Adriaens A, Polis I, et al. Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides. Peptides. 2010;31(7):1390−1399. doi: https://doi.org/10.1016/j.peptides.2010.03.029</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Botros M, Hallberg M, Johansson T, et al. Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in rat spinal cord. Peptides. 2006;27(4):753−759. doi: https://doi.org/10.1016/j.peptides.2005.08.009</mixed-citation><mixed-citation xml:lang="en">Botros M, Hallberg M, Johansson T, et al. Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in rat spinal cord. Peptides. 2006;27(4):753−759. doi: https://doi.org/10.1016/j.peptides.2005.08.009</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Janecka A, Staniszewska R, Gach K, Fichna J. Enzymatic degradation of endomorphins. Peptides. 2008;29(11):2066−2073. doi: https://doi.org/10.1016/j.peptides.2008.07.015</mixed-citation><mixed-citation xml:lang="en">Janecka A, Staniszewska R, Gach K, Fichna J. Enzymatic degradation of endomorphins. Peptides. 2008;29(11):2066−2073. doi: https://doi.org/10.1016/j.peptides.2008.07.015</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Cros CD, Toth I, Blanchfield JT. Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery. Bioorg Med Chem. 2011;19(4):1528−1534. doi: https://doi.org/10.1016/j.bmc.2010.12.042</mixed-citation><mixed-citation xml:lang="en">Cros CD, Toth I, Blanchfield JT. Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery. Bioorg Med Chem. 2011;19(4):1528−1534. doi: https://doi.org/10.1016/j.bmc.2010.12.042</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Falconer RA, Toth I. Design, synthesis and biological evaluation of novel lipoamino acid-based glycolipids for oral drug delivery. Bioorg Med Chem. 2007;15(22):7012−7020. doi: https://doi.org/10.1016/j.bmc.2007.07.048</mixed-citation><mixed-citation xml:lang="en">Falconer RA, Toth I. Design, synthesis and biological evaluation of novel lipoamino acid-based glycolipids for oral drug delivery. Bioorg Med Chem. 2007;15(22):7012−7020. doi: https://doi.org/10.1016/j.bmc.2007.07.048</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Varamini Р, Hussein WM, Mansfeld FM, Toth I. Synthesis, biological activity and structure-activity relationship of endomorphin-1/substance P derivatives. Bioorg Med Chem. 2012;20(21):6335−6343. doi: https://doi.org/10.1016/j.bmc.2012.09.003</mixed-citation><mixed-citation xml:lang="en">Varamini Р, Hussein WM, Mansfeld FM, Toth I. Synthesis, biological activity and structure-activity relationship of endomorphin-1/substance P derivatives. Bioorg Med Chem. 2012;20(21):6335−6343. doi: https://doi.org/10.1016/j.bmc.2012.09.003</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Varamini P, Toth I. Lipid-and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain. Front Pharmacol. 2013;4:155. doi: https://doi.org/10.3389/fphar.2013.00155</mixed-citation><mixed-citation xml:lang="en">Varamini P, Toth I. Lipid-and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain. Front Pharmacol. 2013;4:155. doi: https://doi.org/10.3389/fphar.2013.00155</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Horvath G. Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists. Pharmacol Ther. 2000;88(3):437−463. doi: https://doi.org/10.1016/s0163-7258(00)00100-5</mixed-citation><mixed-citation xml:lang="en">Horvath G. Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists. Pharmacol Ther. 2000;88(3):437−463. doi: https://doi.org/10.1016/s0163-7258(00)00100-5</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sharp BM, Roy S, Bidlack JM. Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol. 1998;83(1−2):45−56. doi: https://doi.org/10.1016/s0165-5728(97)00220-8</mixed-citation><mixed-citation xml:lang="en">Sharp BM, Roy S, Bidlack JM. Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol. 1998;83(1−2):45−56. doi: https://doi.org/10.1016/s0165-5728(97)00220-8</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sakurada S, Zadina JE, Kastin AJ, et al. Differential involvement of μ-opioid receptor subtypes in endomorphin-1-and -2-induced antinociception. Eur J Pharmacol. 1999;372:25−30. doi: https://doi.org/10.1016/s0014-2999(99)00181-8</mixed-citation><mixed-citation xml:lang="en">Sakurada S, Zadina JE, Kastin AJ, et al. Differential involvement of μ-opioid receptor subtypes in endomorphin-1-and -2-induced antinociception. Eur J Pharmacol. 1999;372:25−30. doi: https://doi.org/10.1016/s0014-2999(99)00181-8</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Pasternak GW. Opioids and their receptors: are we there yet? Neuropharmacology. 2014;76 Pt B:198−203. doi: https://doi.org/10.1016/j.neuropharm.2013.03.039</mixed-citation><mixed-citation xml:lang="en">Pasternak GW. Opioids and their receptors: are we there yet? Neuropharmacology. 2014;76 Pt B:198−203. doi: https://doi.org/10.1016/j.neuropharm.2013.03.039</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Geppetti P, Veldhuis NA, Lieu TM, Bunnett NW. G-Protein coupled receptors. Dynamic machines for signaling pain and itch. Neuron. 2015;88(4):635−649. doi: https://doi.org/10.1016/j.neuron.2015.11.001</mixed-citation><mixed-citation xml:lang="en">Geppetti P, Veldhuis NA, Lieu TM, Bunnett NW. G-Protein coupled receptors. Dynamic machines for signaling pain and itch. Neuron. 2015;88(4):635−649. doi: https://doi.org/10.1016/j.neuron.2015.11.001</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rutherford JM, Wang J, Xu H, et al. Evidence for a mu-opioid receptor complex in CHO cells co-expressing mu and delta opioid peptide receptors. Peptides. 2008;29:1424−1431. doi: https://doi.org/10.1016/j.peptides.2008.03.019</mixed-citation><mixed-citation xml:lang="en">Rutherford JM, Wang J, Xu H, et al. Evidence for a mu-opioid receptor complex in CHO cells co-expressing mu and delta opioid peptide receptors. Peptides. 2008;29:1424−1431. doi: https://doi.org/10.1016/j.peptides.2008.03.019</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Shang Y, Filizola M. Opioid receptors: structural and mechanistic insights into pharmacology and signaling. Eur J Pharmacol. 2015;763(Pt B):206−213. doi: https://doi.org/10.1016/j.ejphar.2015.05.012</mixed-citation><mixed-citation xml:lang="en">Shang Y, Filizola M. Opioid receptors: structural and mechanistic insights into pharmacology and signaling. Eur J Pharmacol. 2015;763(Pt B):206−213. doi: https://doi.org/10.1016/j.ejphar.2015.05.012</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Convertino M, Samoshkin A, Gauthier J, et al. μ-Opioid receptor 6-transmembrane isoform: a potential therapeutic target for new effective opioids. Prog Neuropsychopharmacol Biol Psychiatry. 2015;62:61−67. doi: https://doi.org/10.1016/j.pnpbp.2014.11.009</mixed-citation><mixed-citation xml:lang="en">Convertino M, Samoshkin A, Gauthier J, et al. μ-Opioid receptor 6-transmembrane isoform: a potential therapeutic target for new effective opioids. Prog Neuropsychopharmacol Biol Psychiatry. 2015;62:61−67. doi: https://doi.org/10.1016/j.pnpbp.2014.11.009</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Burford NT, Tolber LM, Sadee W. Specific G protein activation and A-opioid receptor internalization caused by morphine, DAMGO and endomorphin-I. Eur J Pharmacol. 1998;342(1):123−126. doi: https://doi.org/10.1016/s0014-2999(97)01556-2</mixed-citation><mixed-citation xml:lang="en">Burford NT, Tolber LM, Sadee W. Specific G protein activation and A-opioid receptor internalization caused by morphine, DAMGO and endomorphin-I. Eur J Pharmacol. 1998;342(1):123−126. doi: https://doi.org/10.1016/s0014-2999(97)01556-2</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Horner KA, Zadina JE. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells. Brain Res. 2004;1028(2):121−132. doi: https://doi.org/10.1016/j.brainres.2004.07.055</mixed-citation><mixed-citation xml:lang="en">Horner KA, Zadina JE. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells. Brain Res. 2004;1028(2):121−132. doi: https://doi.org/10.1016/j.brainres.2004.07.055</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lengyel I, Toth F, Biyashev D, et al. A novel non-opioid binding site for endomorphin-1. J Physiol Pharmacol. 2016;67:605−616</mixed-citation><mixed-citation xml:lang="en">Lengyel I, Toth F, Biyashev D, et al. A novel non-opioid binding site for endomorphin-1. J Physiol Pharmacol. 2016;67:605−616</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kosson P, Bonney I, Carr DB, et al. Endomorphins interact with tachykinin receptors. Peptides. 2005;26(9):1667−1669. doi: https://doi.org/10.1016/j.peptides.2005.02.006</mixed-citation><mixed-citation xml:lang="en">Kosson P, Bonney I, Carr DB, et al. Endomorphins interact with tachykinin receptors. Peptides. 2005;26(9):1667−1669. doi: https://doi.org/10.1016/j.peptides.2005.02.006</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Law PY, Loh H. Neuroactive proteins and peptides. In: Lajtha A, Lim R, ed. Handbook of neurochemistry and molecular neurobiology. Germany: Springer; 2006. Рp. 357–389</mixed-citation><mixed-citation xml:lang="en">Law PY, Loh H. Neuroactive proteins and peptides. In: Lajtha A, Lim R, ed. Handbook of neurochemistry and molecular neurobiology. Germany: Springer; 2006. Рp. 357–389</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Kitanaka N, Kitanaka J, Hall FS, et al. Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawal. Synapse. 2008;62(9):689–699. doi: https://doi.org/10.1002/syn.20543</mixed-citation><mixed-citation xml:lang="en">Kitanaka N, Kitanaka J, Hall FS, et al. Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawal. Synapse. 2008;62(9):689–699. doi: https://doi.org/10.1002/syn.20543</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">McDonald J, Lambert DG. Opioid mechanisms and opioid drugs. Anaesthesia Intensive Care Medicine. 2011;12(1):31–35. doi: https://doi.org/10.1016/j.mpaic.2010.10.008</mixed-citation><mixed-citation xml:lang="en">McDonald J, Lambert DG. Opioid mechanisms and opioid drugs. Anaesthesia Intensive Care Medicine. 2011;12(1):31–35. doi: https://doi.org/10.1016/j.mpaic.2010.10.008</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Sharp BM. Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun. 2006;20:9–14. doi: https://doi.org/10.1016/j.bbi.2005.02.002</mixed-citation><mixed-citation xml:lang="en">Sharp BM. Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun. 2006;20:9–14. doi: https://doi.org/10.1016/j.bbi.2005.02.002</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Nevo I, Avidor-Reiss T, Levy R, et al. Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes. Neuropharmacology. 2000;39(3):364–371. doi: https://doi.org/10.1016/s0028-3908(99)00155-0</mixed-citation><mixed-citation xml:lang="en">Nevo I, Avidor-Reiss T, Levy R, et al. Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes. Neuropharmacology. 2000;39(3):364–371. doi: https://doi.org/10.1016/s0028-3908(99)00155-0</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Zhao H, Qiu Y, et al. Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal. J Biol Chem. 2009;23(4):1990–2000. doi: https://doi.org/10.1074/jbc.M807971200</mixed-citation><mixed-citation xml:lang="en">Zhang L, Zhao H, Qiu Y, et al. Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal. J Biol Chem. 2009;23(4):1990–2000. doi: https://doi.org/10.1074/jbc.M807971200</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Block L, Forshammar J, Westerlund A, et al. Naloxone in ultralow concentration restores endomorphin-1-evoked Ca2+ signaling in lipopolysaccharide pretreated astrocytes. Neuroscience. 2012;205:1–9. doi: https://doi.org/10.1016/j.neuroscience.2011.12.058</mixed-citation><mixed-citation xml:lang="en">Block L, Forshammar J, Westerlund A, et al. Naloxone in ultralow concentration restores endomorphin-1-evoked Ca2+ signaling in lipopolysaccharide pretreated astrocytes. Neuroscience. 2012;205:1–9. doi: https://doi.org/10.1016/j.neuroscience.2011.12.058</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Liu H, Li H, Guo L, et al. Mechanisms involved in phosphatidylinositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes. Biochem Pharmacol. 2010;79(3):516–523. doi: https://doi.org/10.1016/j.bcp.2009.09.013</mixed-citation><mixed-citation xml:lang="en">Liu H, Li H, Guo L, et al. Mechanisms involved in phosphatidylinositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes. Biochem Pharmacol. 2010;79(3):516–523. doi: https://doi.org/10.1016/j.bcp.2009.09.013</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Anton B, Leff P, Calva JC, et al. Endomorphin 1 and endomorphin 2 suppress in vitro antibody formation at ultra-low concentrations: anti-peptide antibodies but not opioid antagonists block the activity. Brain Behav Immun. 2008;22(6):824–832. doi: https://doi.org/10.1016/j.bbi.2008.02.004</mixed-citation><mixed-citation xml:lang="en">Anton B, Leff P, Calva JC, et al. Endomorphin 1 and endomorphin 2 suppress in vitro antibody formation at ultra-low concentrations: anti-peptide antibodies but not opioid antagonists block the activity. Brain Behav Immun. 2008;22(6):824–832. doi: https://doi.org/10.1016/j.bbi.2008.02.004</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Kaczyńska K, Kogut E, Zając D, et al. Neurotensin-based hybrid peptide’s anti-inflammatory activity in murine model of a contact sensitivity response. Eur J Pharm Sci. 2016;93:84−89. doi: https://doi.org/10.1016/j.ejps.2016.08.012.</mixed-citation><mixed-citation xml:lang="en">Kaczyńska K, Kogut E, Zając D, et al. Neurotensin-based hybrid peptide’s anti-inflammatory activity in murine model of a contact sensitivity response. Eur J Pharm Sci. 2016;93:84−89. doi: https://doi.org/10.1016/j.ejps.2016.08.012.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Lin X, Chen Q, Xue LY, et al. Endomorphins, endogenous opioid peptides, induce apoptosis in human leukemia HL-60 cells. Can J Physiol Pharmacol. 2004;82(11):1018−1025. doi: https://doi.org/10.1139/y04-087</mixed-citation><mixed-citation xml:lang="en">Lin X, Chen Q, Xue LY, et al. Endomorphins, endogenous opioid peptides, induce apoptosis in human leukemia HL-60 cells. Can J Physiol Pharmacol. 2004;82(11):1018−1025. doi: https://doi.org/10.1139/y04-087</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Shaffer AD, Ness TJ, Robbins MT, Randich A. Early in life bladder inflammation alters opioid peptide content in the spinal cord and bladder of adult female rats. J Urol. 2013;189(1):352−358. doi: https://doi.org/10.1016/j.juro.2012.08.190</mixed-citation><mixed-citation xml:lang="en">Shaffer AD, Ness TJ, Robbins MT, Randich A. Early in life bladder inflammation alters opioid peptide content in the spinal cord and bladder of adult female rats. J Urol. 2013;189(1):352−358. doi: https://doi.org/10.1016/j.juro.2012.08.190</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Azuma Y, Ohura K. Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-jB DNA binding in THP-1 differentiated to macrophage-like cells. Scand J Immunol. 2002;56(3):209–260. doi: https://doi.org/10.1046/j.1365-3083.2002.01128.x</mixed-citation><mixed-citation xml:lang="en">Azuma Y, Ohura K. Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-jB DNA binding in THP-1 differentiated to macrophage-like cells. Scand J Immunol. 2002;56(3):209–260. doi: https://doi.org/10.1046/j.1365-3083.2002.01128.x</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Azuma Y, Ohura K. Endomorphin-2 modulates productions of TNF-alpha, IL-1beta, IL-10, and IL-12, and alters functions related to innate immune of macrophages. Inflammation. 2002;26(5):223−232. doi: https://doi.org/10.1023/a:1019766602138</mixed-citation><mixed-citation xml:lang="en">Azuma Y, Ohura K. Endomorphin-2 modulates productions of TNF-alpha, IL-1beta, IL-10, and IL-12, and alters functions related to innate immune of macrophages. Inflammation. 2002;26(5):223−232. doi: https://doi.org/10.1023/a:1019766602138</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Beutler B. Application of transcriptional and posttranscriptional reporter constructs to the analysis of tumor necrosis factor gene regulation. Am J Med Sci. 1992;303(2):129–133. doi: https://doi.org/10.1097/00000441-199202000-00015</mixed-citation><mixed-citation xml:lang="en">Beutler B. Application of transcriptional and posttranscriptional reporter constructs to the analysis of tumor necrosis factor gene regulation. Am J Med Sci. 1992;303(2):129–133. doi: https://doi.org/10.1097/00000441-199202000-00015</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Kruys V, Kemmer K, Shakhov A, et al. Constitutive activity of the tumor necrosis factor promoter is canceled by the 3’ untranslated region in non macrophage cell lines; a trans-dominant factor overcomes this suppressive effect. Proc Natl Acad Sci U S A. 1992;89(2):673–677. doi: https://doi.org/10.1073/pnas.89.2.673</mixed-citation><mixed-citation xml:lang="en">Kruys V, Kemmer K, Shakhov A, et al. Constitutive activity of the tumor necrosis factor promoter is canceled by the 3’ untranslated region in non macrophage cell lines; a trans-dominant factor overcomes this suppressive effect. Proc Natl Acad Sci U S A. 1992;89(2):673–677. doi: https://doi.org/10.1073/pnas.89.2.673</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Li WY, Yang JJ, Zhu SH, et al. Endomorphins and ohmefentanyl in the inhibition of immunosuppressant function in rat peritoneal macrophages: An experimental in vitro study. Curr Ther Res. 2008;69(1):56−64. doi: https://doi.org/10.1016/j.curtheres.2008.02.004</mixed-citation><mixed-citation xml:lang="en">Li WY, Yang JJ, Zhu SH, et al. Endomorphins and ohmefentanyl in the inhibition of immunosuppressant function in rat peritoneal macrophages: An experimental in vitro study. Curr Ther Res. 2008;69(1):56−64. doi: https://doi.org/10.1016/j.curtheres.2008.02.004</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Chiurchiu V, Izzi V, Aquilio FD, et al. Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages. Peptides. 2011;32(1):80–85. doi: https://doi.org/10.1016/j.peptides.2010.09.024</mixed-citation><mixed-citation xml:lang="en">Chiurchiu V, Izzi V, Aquilio FD, et al. Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages. Peptides. 2011;32(1):80–85. doi: https://doi.org/10.1016/j.peptides.2010.09.024</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Neudeck BL, Loeb JM. Endomorphin-1 alters interleukin-8 secretion in caco-2 cells via a receptor mediated process. Immunol Lett. 2002;84(3):217–221. doi: https://doi.org/10.1016/s0165-2478(02)00198-0</mixed-citation><mixed-citation xml:lang="en">Neudeck BL, Loeb JM. Endomorphin-1 alters interleukin-8 secretion in caco-2 cells via a receptor mediated process. Immunol Lett. 2002;84(3):217–221. doi: https://doi.org/10.1016/s0165-2478(02)00198-0</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Inui Y, Azuma Y, Ohura K. Differential alteration of functions of rat peritoneal macrophages responsive to endogenous opioid peptide endomorphin-1. Int Immunopharmacol. 2002;2(8):1133−1142. doi: https://doi.org/10.1016/S1567-5769(02)00065-6</mixed-citation><mixed-citation xml:lang="en">Inui Y, Azuma Y, Ohura K. Differential alteration of functions of rat peritoneal macrophages responsive to endogenous opioid peptide endomorphin-1. Int Immunopharmacol. 2002;2(8):1133−1142. doi: https://doi.org/10.1016/S1567-5769(02)00065-6</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Azuma Y, Wang P-L, Shinohara M, Ohura K. Immunomodulation of the neutrophil respiratory burst by endomorphins 1 and 2. Immunol Lett. 2000;75(1):55–59. doi: https://doi.org/10.1016/s0165-2478(00)00274-1</mixed-citation><mixed-citation xml:lang="en">Azuma Y, Wang P-L, Shinohara M, Ohura K. Immunomodulation of the neutrophil respiratory burst by endomorphins 1 and 2. Immunol Lett. 2000;75(1):55–59. doi: https://doi.org/10.1016/s0165-2478(00)00274-1</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Azuma Y, Ohura K, Wang PL, Shinohara M. Endomorphins delay constitutive apoptosis and alter the innate host defense functions of neutrophils. Immunol Lett. 2002;81(1):31–40. doi: https://doi.org/10.1016/s0165-2478(01)00335-2</mixed-citation><mixed-citation xml:lang="en">Azuma Y, Ohura K, Wang PL, Shinohara M. Endomorphins delay constitutive apoptosis and alter the innate host defense functions of neutrophils. Immunol Lett. 2002;81(1):31–40. doi: https://doi.org/10.1016/s0165-2478(01)00335-2</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Tseng LF, Narita M, Suganuma C, et al. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther. 2000;292(2):576−583</mixed-citation><mixed-citation xml:lang="en">Tseng LF, Narita M, Suganuma C, et al. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther. 2000;292(2):576−583</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Sedqi M, Roy S, Ramakrishnan S, et al. Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun. 1995;209(2):563−574. doi: https://doi.org/10.1006/bbrc.1995.1538</mixed-citation><mixed-citation xml:lang="en">Sedqi M, Roy S, Ramakrishnan S, et al. Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun. 1995;209(2):563−574. doi: https://doi.org/10.1006/bbrc.1995.1538</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Šaric A, Balog T, Sobocanec S, Marotti T. Endomorphin 1 activates nitric oxide synthase 2 activity аnd downregulates nitric oxide synthase 2 mRNA еxpression. Neuroscience. 2007;144(4):1454–1461. doi: https://doi.org/10.1016/j.neuroscience.2006.11.020</mixed-citation><mixed-citation xml:lang="en">Šaric A, Balog T, Sobocanec S, Marotti T. Endomorphin 1 activates nitric oxide synthase 2 activity аnd downregulates nitric oxide synthase 2 mRNA еxpression. Neuroscience. 2007;144(4):1454–1461. doi: https://doi.org/10.1016/j.neuroscience.2006.11.020</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Balog T, Saric A, Sobocanec S, et al. Endomorphin-suppressed nitric oxide release from mice peritoneal macrophages. Neuropeptides. 2010;44(1):25–29. doi: https://doi.org/10.1016/j.npep.2009.11.004</mixed-citation><mixed-citation xml:lang="en">Balog T, Saric A, Sobocanec S, et al. Endomorphin-suppressed nitric oxide release from mice peritoneal macrophages. Neuropeptides. 2010;44(1):25–29. doi: https://doi.org/10.1016/j.npep.2009.11.004</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L, Wang Y, Pan Z, et al. [Endomorphine-1 inhibits maturation and functions of human peripheral blood-derived dendritic cells. (In Chinese)]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32(4):527−531</mixed-citation><mixed-citation xml:lang="en">Yang L, Wang Y, Pan Z, et al. [Endomorphine-1 inhibits maturation and functions of human peripheral blood-derived dendritic cells. (In Chinese)]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32(4):527−531</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Liu CM, Yang TH, Huang M, et al. [Effect of endomorphin-1 on maturation and expression of TLR4 in peripheral blood dendritic cells induced by high glucose. (In Chinese)]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018;26(3):886−893. doi: https://doi.org/10.7534/j.issn.1009-2137.2018.03.043</mixed-citation><mixed-citation xml:lang="en">Liu CM, Yang TH, Huang M, et al. [Effect of endomorphin-1 on maturation and expression of TLR4 in peripheral blood dendritic cells induced by high glucose. (In Chinese)]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018;26(3):886−893. doi: https://doi.org/10.7534/j.issn.1009-2137.2018.03.043</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Peterson PK, Gekker G, Hu S, et al. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implications of an atypical mu-opioid receptor. Neuropharmacology. 1999;38(2):273–278. doi: https://doi.org/10.1016/s0028-3908(98)00167-1</mixed-citation><mixed-citation xml:lang="en">Peterson PK, Gekker G, Hu S, et al. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implications of an atypical mu-opioid receptor. Neuropharmacology. 1999;38(2):273–278. doi: https://doi.org/10.1016/s0028-3908(98)00167-1</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Dai X, Song HJ, Cui SG, et al. The stimulative effects of endogenous opioids on endothelial cell proliferation, migration and angiogenesis in vitro. Eur J Pharmacol. 2010;628(1−3):42–50. doi: https://doi.org/10.1016/j.ejphar.2009.11.035</mixed-citation><mixed-citation xml:lang="en">Dai X, Song HJ, Cui SG, et al. The stimulative effects of endogenous opioids on endothelial cell proliferation, migration and angiogenesis in vitro. Eur J Pharmacol. 2010;628(1−3):42–50. doi: https://doi.org/10.1016/j.ejphar.2009.11.035</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Carrigan KA, Nelson CJ, Lysle DT. Endomorphin-1 induces antinociception without immunomodulatory effects in the rat. Psychopharmacology. 2000;151(4):299–305. doi: https://doi.org/10.1007/s002130000487</mixed-citation><mixed-citation xml:lang="en">Carrigan KA, Nelson CJ, Lysle DT. Endomorphin-1 induces antinociception without immunomodulatory effects in the rat. Psychopharmacology. 2000;151(4):299–305. doi: https://doi.org/10.1007/s002130000487</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Hernandez MC, Flores LR, Bayer BM. Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther. 1993;267(3):1336–1341</mixed-citation><mixed-citation xml:lang="en">Hernandez MC, Flores LR, Bayer BM. Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther. 1993;267(3):1336–1341</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Plein LM, Rittner HL. Opioids and the immune system — friend or foe. Br J Pharmacol. 2018;175(14):2717–2725. doi: https://doi.org/10.1111/bph.13750</mixed-citation><mixed-citation xml:lang="en">Plein LM, Rittner HL. Opioids and the immune system — friend or foe. Br J Pharmacol. 2018;175(14):2717–2725. doi: https://doi.org/10.1111/bph.13750</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Гейн С.В., Баева Т.А., Гейн О.Н., Черешнев В.А. Роль моноцитов в реализации эффектов β-эндорфина и селективных агонистов μ- и δ-опиатных рецепторов на пролиферативную активность лимфоцитов периферической крови // Физиология человека. — 2006. — Т.32. — №3. — С. 111−116. [Gein SV, Baeva TA, Gein ON, Chereshnev VA. The role of monocytes in the effects of β-endorphin and selective agonists of μ-and δ-opiate receptors on the proliferative activity of peripheral blood lymphocytes. Human Physiology. 2006;32(3):111–116. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Гейн С.В., Баева Т.А., Гейн О.Н., Черешнев В.А. Роль моноцитов в реализации эффектов β-эндорфина и селективных агонистов μ- и δ-опиатных рецепторов на пролиферативную активность лимфоцитов периферической крови // Физиология человека. — 2006. — Т.32. — №3. — С. 111−116. [Gein SV, Baeva TA, Gein ON, Chereshnev VA. The role of monocytes in the effects of β-endorphin and selective agonists of μ-and δ-opiate receptors on the proliferative activity of peripheral blood lymphocytes. Human Physiology. 2006;32(3):111–116. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Li W, Chen W, Herberman RB, et al. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK). Cancer Lett. 2014;344(2):212−222. doi: https://doi.org/10.1016/j.canlet.2013.10.029</mixed-citation><mixed-citation xml:lang="en">Li W, Chen W, Herberman RB, et al. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK). Cancer Lett. 2014;344(2):212−222. doi: https://doi.org/10.1016/j.canlet.2013.10.029</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Manglik A, Kruse AC, Kobilka TS, et al. Crystal structure of the m-opioid receptor bound to a morphinan antagonist. Nature. 2012;485(7398):321−326. doi: https://doi.org/10.1038/nature10954</mixed-citation><mixed-citation xml:lang="en">Manglik A, Kruse AC, Kobilka TS, et al. Crystal structure of the m-opioid receptor bound to a morphinan antagonist. Nature. 2012;485(7398):321−326. doi: https://doi.org/10.1038/nature10954</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Bechara C, Sagan S. Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett. 2013;587(12):1693−1702. doi: https://doi.org/10.1016/j.febslet.2013.04.031</mixed-citation><mixed-citation xml:lang="en">Bechara C, Sagan S. Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett. 2013;587(12):1693−1702. doi: https://doi.org/10.1016/j.febslet.2013.04.031</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Wender PA, Mitchell DJ, Pattabiraman K, et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A. 2000;97(24):13003–13008. doi: https://doi.org/10.1073/pnas.97.24.13003</mixed-citation><mixed-citation xml:lang="en">Wender PA, Mitchell DJ, Pattabiraman K, et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A. 2000;97(24):13003–13008. doi: https://doi.org/10.1073/pnas.97.24.13003</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Gu ZH, Wang B, Kou ZZ, et al. Endomorphins: promising endogenous opioid peptides for the development of novel analgesics. Neurosignals. 2017;25(1):98−116. doi: https://doi.org/10.1159/000484909</mixed-citation><mixed-citation xml:lang="en">Gu ZH, Wang B, Kou ZZ, et al. Endomorphins: promising endogenous opioid peptides for the development of novel analgesics. Neurosignals. 2017;25(1):98−116. doi: https://doi.org/10.1159/000484909</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
